ATE315649T1 - Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung - Google Patents

Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung

Info

Publication number
ATE315649T1
ATE315649T1 AT00977578T AT00977578T ATE315649T1 AT E315649 T1 ATE315649 T1 AT E315649T1 AT 00977578 T AT00977578 T AT 00977578T AT 00977578 T AT00977578 T AT 00977578T AT E315649 T1 ATE315649 T1 AT E315649T1
Authority
AT
Austria
Prior art keywords
mycoides
protein
subsp
lppq
detection
Prior art date
Application number
AT00977578T
Other languages
English (en)
Inventor
Joachim Frey
Jacques Nicolet
El-Mostafa Abdo
Original Assignee
Akzo Nobel Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nobel Nv filed Critical Akzo Nobel Nv
Application granted granted Critical
Publication of ATE315649T1 publication Critical patent/ATE315649T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/30—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Mycoplasmatales, e.g. Pleuropneumonia-like organisms [PPLO]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/53—DNA (RNA) vaccination
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biophysics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT00977578T 1999-11-29 2000-11-24 Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung ATE315649T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP99123676 1999-11-29

Publications (1)

Publication Number Publication Date
ATE315649T1 true ATE315649T1 (de) 2006-02-15

Family

ID=8239477

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00977578T ATE315649T1 (de) 1999-11-29 2000-11-24 Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung

Country Status (7)

Country Link
EP (1) EP1240328B1 (de)
JP (1) JP2003515340A (de)
AT (1) ATE315649T1 (de)
AU (1) AU777145B2 (de)
DE (1) DE60025522T2 (de)
ES (1) ES2256062T3 (de)
WO (1) WO2001040471A1 (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI350174B (en) * 2003-03-12 2011-10-11 Wyeth Corp Adjuvanted bovine vaccines
SE0301436D0 (sv) * 2003-05-16 2003-05-16 Joakim Westberg New proteins
CN1300318C (zh) * 2004-08-05 2007-02-14 中国农业科学院哈尔滨兽医研究所 一种编码丝状支原体丝状亚种n端脂蛋白的dna
CN110483625A (zh) * 2019-06-20 2019-11-22 华中农业大学 一种牛支原体假想蛋白MbovP732及其应用
CN118903475B (zh) * 2024-10-09 2025-04-18 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 重组蛋白rMmm604在抗丝状支原体丝状亚种感染中的应用

Also Published As

Publication number Publication date
WO2001040471A1 (en) 2001-06-07
AU777145B2 (en) 2004-10-07
JP2003515340A (ja) 2003-05-07
EP1240328A1 (de) 2002-09-18
EP1240328B1 (de) 2006-01-11
ES2256062T3 (es) 2006-07-16
DE60025522T2 (de) 2006-07-06
DE60025522D1 (de) 2006-04-06
AU1524001A (en) 2001-06-12

Similar Documents

Publication Publication Date Title
ATE348887T1 (de) Streptococcus pneumoniae antigene und impfstoffe
EP2261358A3 (de) Streptokokken-Antigene
WO2001031019A3 (en) Neisserial antigenic peptides
NO976119D0 (no) OMP26-antigen fra Haemophilus influenzae
US10168330B2 (en) Marker system, in particular for baculovirus-expressed subunit antigens
NO20004161L (no) Gruppe B streptokoccus antigener
DE60120621D1 (de) Lawsonia intracellularis Impfstoff
WO2004102198A3 (en) Selection of b cells with specificity of interest: method of preparation and use
ATE109512T1 (de) Expression und diagnose mit gag-kodierten peptiden, die mit antikörpern gegen lav immunologisch reaktiv sind.
ATE159170T1 (de) Impfstoffe und diagnosetest für haemophilus influenzae
DE60025522D1 (de) Mycoplasma mycoides subsp. mycoides sc antigenisches lppq protein, seine herstellung und verwendung
DE602004024423D1 (de) Impfstoff mit lawsonia intracellularis-untereinheit
ATE124420T1 (de) Impfstoffe und testsätze für haemophilus influenzae.
RU2012111811A (ru) Белки, используемые для диагностики лайм-боррелиоза
CN106397549B (zh) MERS-CoV特异性多肽及其应用
CN110862969B (zh) 分泌抗cfp-10抗体的杂交瘤细胞株、其抗体及其应用
DE502004008729D1 (de) Gegen das Prothrombin-Fragment F1+2 gerichtete Antikörper, ihre Herstellung und Verwendung
RU2663003C1 (ru) Штамм культивируемых гибридных клеток животного mus musculus-продуцент моноклонального антитела к мембранному белку, общему для тср+ штаммов холерных вибрионов о1 и о139 серогрупп
CN105273082A (zh) 一种gfp多克隆抗体的制备方法
Mao et al. Expression and immunogenicity of recombinant glycoprotein D of herpes simplex virus 1 in Drosophila S2 cells
WO2018018123A3 (pt) Neutralizing anti-tetanus human monoclonal antibodies for c tetani infection, method of obtaining said monoclonal antibodies and their use in immunotherapy for accidents sussceptible to tetanus bacillus infection
WO2002077648A3 (en) Pathogenic and commensal vaccine antigens
SE9804491D0 (sv) Novel fibronectin-binding protein
RU2198922C2 (ru) Штамм гибридных клеток r1/s-5a6 животных mus musculus l., продуцирующих моноклональные антитела к риккетсиям провачека
WO2000045839A3 (en) A method for selecting and producing vaccine and diagnostic preparations

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties